期刊文献+

Y111是维持血管内皮细胞生长抑制因子生物活性的关键氨基酸 被引量:1

The structure-function relationship analysis of VEGI: Y111 is an important residue in biological activity
下载PDF
导出
摘要 目的血管内皮细胞生长抑制因子(Vascu lar endothe-lial cell growth inh ib itor,VEG I)是近年来发现的一类TNF家族新成员,具有抑制内皮细胞增殖与新生血管生成的作用。但目前其结构功能关系研究尚为空白,该文研究VEG I空间结构上重要残基的作用极其对生物活性的影响。方法采用定点突变技术突变了四个关键氨基酸E45R,G47A,Y111F,Y111T,构建了表达载体并在大肠肝菌中表达及纯化,采用人脐静脉内皮细胞增殖和鸡胚尿囊膜血管生成实验研究了四个突变体的活性。结果E45R突变体的活性显著下降,G47A突变体的活性略低于野生型VEG I,Y111F,Y111T突变体的活性比野生型VEGI下降10倍以上。结论VEGI的第111位氨基酸Y是发挥其功能的关键氨基酸,可能与受体形成直接结合,且氨基酸Y上的苯环与酚羟基均对其活性的发挥具重要作用;第45位氨基酸E对其活性的发挥也具重要作用,而第47氨基酸对其活性的发挥可能不具重要作用。 Aim Vascular endothelial cell growth inhibitor(VEGI) is a recently discovered novel member of the TNF superfamily, which is expressed predominantly in endothelial cells. As an endothelial cell-specific negative regulator of angiogenesis, the relationship between structure and function of VEGI is not understood at present. Methods In order to explore the functional key amino acids of VEGI, four mutants of VEGI(E45→R,G47→A,Y111→F, Y111→T) were construced by site-directed mutagenesis, and recombinant proteins were generated from E. coli. Four mutant proteins behaved similar to the wild type VEGI in various physico-chemical assays. The proliferation of HUVEC and chick choriallantic membrane assay were performed to study the activity of four mutants. Results The mutant E45→R significantly decreased the biological activity, and the mutant G47→ A caused a slight drop on activity, but the mutants Y111→F, Y111→T almost completely abolished biological activity. Conclusion It suggests that Y111 is an important residue in biological activity, which may play a direct role in receptor recognition. Moreover, the tyrosine ring and hydroxy group of the amino acid are important determinant of biological activity. Additionally, E45 also plays an important role in biological activity of VEGI.
出处 《中国药理学通报》 CAS CSCD 北大核心 2006年第3期302-306,共5页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No3P825116)
关键词 血管内皮细胞生长抑制因子(VEGI) 内皮细胞 定点突变 生物学活性 VEGI endothelial cells site-directedmutagenesis biological activity
  • 相关文献

参考文献18

  • 1Tan K B,Harrop J,Reddy M,et al.Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells[J].Gene,1997,204(1-2):35-46.
  • 2Zhai Y,Ni J,Jiang G W,et al.VEGI,a novel cytokine of the tumor necrosis factor family,is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo[J].FASEB J,1999,13(1):181~9.
  • 3Yue T L,Ni J,Romanic A M,et al.TL1,a novel tumor necrosis factor-like cytokine,induces apoptosis in endothelial cells.Involvement of activation of stress protein kinases (stress-activated protein kinase and p38 mitogen-activated protein kinase) and caspase-3-like protease[J].J Biol Chem,1999,274(3):1479-86.
  • 4Zhai Y,Yu J,Iruela-Arispe L,et al.Inhibition of angiogenesis and breast cancer xenograft tumor growth by VEGI,a novel cytokine of the TNF superfamily[J].Int J Cancer,1999,82(1):131-6.
  • 5Yu J,Tian S,Netheny-Baxlow L,et al.Modulation of endothelial cell growth arrest and apoptosis by vascular endothelial growth inhibitor[J].Circ Res,2001,89(12):1161-7.
  • 6王晓庆,梁中琴,顾振纶,范盘生.槲皮素抑制血管生成作用的实验研究[J].中国药理学通报,2004,20(10):1161-1164. 被引量:37
  • 7付生法,陆应麟,张朝山,陈坤.检测血管生长因子作用的鸡胚绒毛尿囊膜技术[J].军事医学科学院院刊,1993,17(4):294-297. 被引量:129
  • 8Yamagishi J,Kawashima H,Matsuo N,et al.Mutational analysis of structure-activity relationships in human tumor necrosis factor-alpha[J].Protein Eng,1990,3(8):713-9.
  • 9Reed C,Fu Z,Wu J,et al.Crystal structure of TNFα mutant R31D with greater affinity for receptor R1 compared with R2[J].Protein Engineering,1997,10(10):1101-7.
  • 10Ostade X,Tavernier J,Prange T,et al.Licalization of the active site of human tumor necrosis factor by mutant analysis[J].EMBO,1991,10(4):827-36.

二级参考文献11

  • 1付生法,陆应麟,张朝山,陈坤.检测血管生长因子作用的鸡胚绒毛尿囊膜技术[J].军事医学科学院院刊,1993,17(4):294-297. 被引量:129
  • 2姜志钢,解剖学报,1989年,12卷,142页
  • 3Folkman J.Tumor angiogenesis: therapeutic implications[J]. N Engl J Med,1971,285(21):1182-6.
  • 4Matias AA. Quercetin mediates the down-regulation of mutant p53 in human breast cancer cell line MDA-MB468[J].Cancer Res,1994,54:2424-35.
  • 5Larocca LM. Quercetin inhibits the growth of leukemik progenitors and induces the expression of thansforming growth factor-β1 in cells Blood[J],1995,85(912):3654-62.
  • 6Piantell M. Tamoxifen and quercetin interact with type Ⅱ estrogen bingding sits and inhibit the growh of human melanoma cells[J]. J Invest Dermal,1995,105(20):248-75.
  • 7Lei H, An P, Song S et al.A novel peptide isolated from a phage display library inhibits tumor growth and metastases by blocking the bingding of vascular endothelial growth factor to its kinase domain receptor[J].The Journal of Biological Chemistry, 2002,277(45) :43137-42.
  • 8Jaffe EA. Culture of human endothelial cells derives from human umbilical veins[J].Circulation,1972,46(2):211-53.
  • 9Tan WF, Lin LP, Li MH et al.Quercetin ,a dietary-derived flavonoid, possesses antiangiogenic potential[J].European Journal of Pharmacology,2003,495: 255-62.
  • 10Fan PS, Gu ZL, Sheng R et al.Inhibitory effect of quercetin on proliferation of human microvascular endothelial cells in vitro[J]. Acta Pharmacologica Sinica,2003,24(12):1231-4.

共引文献173

同被引文献21

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部